‘Game-changing’ partnership announced for emerging exosome field 24-Nov-2022 By Jane Byrne Sartorius BIA Separations and Exopharm are teaming up on research to develop integrated technology for large-scale exosome production.
Glenzocimab to enter Phase 2 trial for heart attack patients 24-Nov-2022 By Rachel Arthur A Phase 2b study will test the tolerance and efficacy of glenzocimab to reduce heart damage following myocardial infarction.
FDA approves first gene therapy for hemophilia B 24-Nov-2022 By Rachel Arthur CSL’s Hemgenix (etranacogene dezaparvovec-drlb) becomes the first treatment to offer patients freedom from regular ongoing infusions.
